Endothelial dysfunction in patients with type 2 diabetes post acute coronary syndrome

Diabetes and Vascular Disease Research

Volumn 10, Issue 4, 2013, Pages 368-374

  Lumsden, Natalie G ^a   Andrews, Karen L ^a   Bobadilla, Maria ^b   Moore, Xiao L ^a   Sampson, Amanda K ^a   Shaw, James A ^a,c   Mizrahi, Jacques ^b   Kaye, David M ^a,c   Dart, Anthony M ^a,c   Chin Dusting, Jaye P F ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c Cardiovascular Medicine Services   (Australia)

Author keywords

acute coronary syndrome; endothelial dysfunction; endothelial microparticles; peripheral arterial tonometry; plethysmography; Type 2 diabetes

Indexed keywords

ACETYLCHOLINE; CD31 ANTIGEN; FIBRINOGEN RECEPTOR; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ACUTE CORONARY SYNDROME; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL MICROPARTICLES; PERIPHERAL ARTERIAL TONOMETRY; PLETHYSMOGRAPHY; TYPE 2 DIABETES;

ACUTE CORONARY SYNDROME; ADULT; AGED; BLOOD PLATELETS; BLOOD PRESSURE; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; MALE; MIDDLE AGED; RISK FACTORS;

EID: 84879328348     PISSN: 14791641     EISSN: 17528984     Source Type: Journal    
DOI: 10.1177/1479164113482593     Document Type: Article

References (40)

1. Shaw JE, Sicree RA, Zimmet PZ.. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010 ; 87: 4-14
2. Garcia MJ, McNamara PM, Gordon T, et al. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes. 1974 ; 23: 105-111
3. Haffner SM, Lehto S, Rönnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med. 1998 ; 339: 229-234
4. Stamler J, Vaccaro O, Neaton JD, et al. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care. 1993 ; 16: 434-444
5. Wei M, Gaskill SP, Haffner SM, et al. Effects of diabetes and level of glycemia on all-cause and cardiovascular mortality. The San Antonio Heart Study. Diabetes Care. 1998 ; 21: 1167-1172
6. Donahoe SM, Stewart GC, McCabe CH, et al. Diabetes and mortality following acute coronary syndromes. JAMA. 2007 ; 298: 765-775
7. Amin AP, Marso SP.. Acute coronary syndrome in the patient with diabetes: is the management different?. Curr Cardiol Rep. 2010 ; 12: 321-329
8. Fichtlscherer S, Breuer S, Zeiher AM.. Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes: further evidence for the existence of the 'vulnerable' patient. Circulation. 2004 ; 110: 1926-1932
9. Reriani MK, Dunlay SM, Gupta B, et al. Effects of statins on coronary and peripheral endothelial function in humans: a systematic review and meta-analysis of randomized controlled trials. Eur J Cardiovasc Prev Rehabil. 2011 ; 18: 704-716
10. Hamilton SJ, Chew GT, Watts GF.. Therapeutic regulation of endothelial dysfunction in type 2 diabetes mellitus. Diab Vasc Dis Res. 2007 ; 4: 89-102
11. Kitta Y, Obata JE, Nakamura T, et al. Persistent impairment of endothelial vasomotor function has a negative impact on outcome in patients with coronary artery disease. J Am Coll Cardiol. 2009 ; 53: 323-330
12. Suessenbacher A, Frick M, Alber HF, et al. Association of improvement of brachial artery flow-mediated vasodilation with cardiovascular events. Vasc Med. 2006 ; 11: 239-244
13. Rautou A-CV, Nicolas A, Gilles C, et al. Microparticles, vascular function, and atherothrombosis. Circ Res. 2011 ; 109: 593-606
14. Tramontano AF, Lyubarova R, Tsiakos J, et al. Circulating endothelial microparticles in diabetes mellitus. Mediators Inflamm. 2010 ; 2010: 250476
15. Sinning JM, Losch J, Walenta K, et al. Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes. Eur Heart J. 2011 ; 32: 2034-2041
16. Tramontano AF, O'Leary J, Black AD, et al. Statin decreases endothelial microparticle release from human coronary artery endothelial cells: implication for the Rho-kinase pathway. Biochem Biophys Res Commun. 2004 ; 320: 34-38
17. Nomura S.. Dynamic role of microparticles in type 2 diabetes mellitus. Curr Diabetes Rev. 2009 ; 5: 245-251
18. Agouni A, Lagrue-Lak-Hal AH, Ducluzeau PH, et al. Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. Am J Pathol. 2008 ; 173: 1210-1219
19. Feng B, Chen Y, Luo Y, et al. Circulating level of microparticles and their correlation with arterial elasticity and endothelium-dependent dilation in patients with type 2 diabetes mellitus. Atherosclerosis. 2010 ; 208: 264-269
20. Boak LM, Dart AM, Duffy SJ, et al. Responses to neither exogenous nor endogenous endothelin-1 are altered in patients with hypercholesterolemia. J Lipid Res. 2005 ; 46: 2667-2672
21. Montes M, Jaensson EA, Orozco AF, et al. A general method for bead-enhanced quantitation by flow cytometry. J Immunol Methods. 2006 ; 317: 45-55
22. Lerman A, Zeiher AM.. Endothelial function: cardiac events. Circulation. 2005 ; 111: 363-368
23. Versari D, Virdis A, Ghiadoni L, et al. Effect of verapamil, trandolapril and their combination on vascular function and structure in essential hypertensive patients. Atherosclerosis. 2009 ; 205: 214-220
24. Jamerson KA. Avoiding cardiovascular events in combination therapy in patients living with systolic hypertension. Paper presented at: American College of Cardiology 57th annual scientific session ; Chicago, IL ;..
25. Versari D, Daghini E, Virdis A, et al. Endothelial dysfunction as a target for prevention of cardiovascular disease. Diabetes Care. 2009 ; 32: S314 - S321
26. Dai YL, Luk TH, Siu CW, et al. Mitochondrial dysfunction induced by statin contributes to endothelial dysfunction in patients with coronary artery disease. Cardiovasc Toxicol. 2010 ; 10: 130-138
27. Patvardhan EA, Heffernan KS, Ruan JM, et al. Assessment of vascular endothelial function with peripheral arterial tonometry: information at your fingertips?. Cardiol Rev. 2010 ; 18: 20-28
28. Hamburg NM, Keyes MJ, Larson MG, et al. Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation. 2008 ; 117: 2467-2474
29. Aversa A, Vitale C, Volterrani M, et al. Chronic administration of Sildenafil improves markers of endothelial function in men with type 2 diabetes. Diabet Med. 2008 ; 25: 37-44
30. Nohria A, Gerhard-Herman M, Creager MA, et al. Role of nitric oxide in the regulation of digital pulse volume amplitude in humans. J Appl Physiol. 2006 ; 101: 545-548
31. McVeigh GE, Brennan GM, Johnston GD, et al. Impaired endothelium- dependent and independent vasodilation in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1992 ; 35: 771-776
32. Ting HH, Timimi FK, Boles KS, et al. Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest. 1996 ; 97: 22-28
33. Williams SB, Cusco JA, Roddy MA, et al. Impaired nitric oxide-mediated vasodilation in patients with non-insulin-dependent diabetes mellitus. J Am Coll Cardiol. 1996 ; 27: 567-574
34. Koga H, Sugiyama S, Kugiyama K, et al. Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. J Am Coll Cardiol. 2005 ; 45: 1622-1630
35. Feng B, Chen Y, Luo Y, et al. Circulating level of microparticles and their correlation with arterial elasticity and endothelium-dependent dilation in patients with type 2 diabetes mellitus. Atherosclerosis. 2010 ; 208: 264-269
36. Bernal-Mizrachi L, Jy W, Jimenez JJ, et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J. 2003 ; 145: 962-970
37. Morel O, Jesel L, Hugel B, et al. Protective effects of vitamin C on endothelium damage and platelet activation during myocardial infarction in patients with sustained generation of circulating microparticles. J Thromb Haemost. 2003 ; 1: 171-177
38. Nomura S, Inami N, Kimura Y, et al. Effect of nifedipine on adiponectin in hypertensive patients with type 2 diabetes mellitus. J Hum Hypertens. 2007 ; 21: 38-44
39. Nomura S, Shouzu A, Omoto S, et al. Benidipine improves oxidized LDL-dependent monocyte and endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus. J Hum Hypertens. 2005 ; 19: 551-557
40. Diamant M, Tushuizen ME, Abid-Hussein MN, et al. Simvastatin-induced endothelial cell detachment and microparticle release are prenylation dependent. Thromb Haemost. 2008 ; 100: 489-497